Cargando…

Enhancing onchocerciasis elimination program management: A biological approach to deciding when to begin Stop Mass Drug Administration activities

Understanding when it is the appropriate time to stop administering the drugs in a chemotherapy-centered treatment program such as onchocerciasis remains a challenge due to cost, imperfect testing procedures, and a lack of long-term experience. Different approaches for assessing when a program can b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boakye, Daniel, Mackenzie, Charles, Tallant, Jamie, Heggen, Anne, Leff, Sashi, Nadjilar, Lokemla, Sow, Moussa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10343055/ https://www.ncbi.nlm.nih.gov/pubmed/37440479 http://dx.doi.org/10.1371/journal.pntd.0011348

Ejemplares similares

Progress towards elimination of onchocerciasis transmission in Mali: A “pre-stop MDA” survey in 18 transmission zones
por: Dolo, Housseini, et al.
Publicado: (2023)

Rethinking the serological threshold for onchocerciasis elimination
por: Gass, Katherine M.
Publicado: (2018)

Refocusing vector assessment towards the elimination of onchocerciasis from Africa: a review of the current status in selected countries
por: Boakye, Daniel, et al.
Publicado: (2018)

Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis
por: Jawahar, Shabnam, et al.
Publicado: (2021)

The onchocerciasis hypothesis of nodding syndrome
por: Colebunders, Robert, et al.
Publicado: (2023)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa
por: Fischer, Peter U., et al.
Publicado: (2017)

Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2022)

Onchocerciasis: the beginning of the end?
por: Hopkins, Adrian
Publicado: (2019)

Navigating the way to onchocerciasis elimination: the feasibility and affordability of Onchocerciasis Elimination Mapping
por: Hamill, Louise, et al.
Publicado: (2022)

Correction: Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2023)

The P Value Line Dance: When Does the Music Stop?
por: Bendtsen, Marcus
Publicado: (2020)

Beginning of the end of Onchocerciasis in the Americas
por: Palma, Gloria I., et al.
Publicado: (2013)

The need for evidence-based strategies and tools for onchocerciasis elimination in Africa
por: Dadzie, Yankum, et al.
Publicado: (2019)

Chemotherapy in the treatment, control, and elimination of human onchocerciasis
por: Higazi, Tarig B, et al.
Publicado: (2014)

Corrigendum to: Navigating the way to onchocerciasis elimination: the feasibility and affordability of Onchocerciasis Elimination Mapping
Publicado: (2022)

Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé Foci, Mali
por: Dolo, Housseini, et al.
Publicado: (2020)

Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination
por: Alley, William Soumbey, et al.
Publicado: (2001)

How to decide intervention thresholds based on FRAX in central south Chinese postmenopausal women
por: Zhang, Zhimin, et al.
Publicado: (2013)

Patient, sufferer, victim, casualty or person with cervical myelopathy: let us decide our identifier
por: Boerger, Timothy F, et al.
Publicado: (2020)

African Programme for Onchocerciasis Control 1995–2015: Updated Health Impact Estimates Based on New Disability Weights
por: Coffeng, Luc E., et al.
Publicado: (2014)

Deciding when to stop: efficient experimentation to learn to predict drug-target interactions
por: Temerinac-Ott, Maja, et al.
Publicado: (2015)

Status of Onchocerciasis Transmission after More Than a Decade of Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis Elimination in Central Nigeria: Challenges in Coordinating the Stop MDA Decision
por: Evans, Darin S., et al.
Publicado: (2014)

Elimination of Onchocerciasis from Mexico
por: Rodríguez-Pérez, Mario A., et al.
Publicado: (2015)

Diagnostics for onchocerciasis in the era of elimination
por: Unnasch, Thomas R, et al.
Publicado: (2018)

Onchocerciasis Elimination: Progress and Challenges
por: Lakwo, Thomson, et al.
Publicado: (2020)

The Real Era of the Art of Medicine Begins with Artificial Intelligence
por: Meskó, Bertalan
Publicado: (2019)

How much diagnostic safety can we afford, and how should we decide? A health economics perspective
por: Newman-Toker, David E, et al.
Publicado: (2013)

The Precision of Cardiovascular Disease Prevention Begins With a Zip Code
por: Obuobi, Shirlene, et al.
Publicado: (2021)

The approval of the first malaria vaccine: The beginning of the end of the malaria epidemic
por: Olufadewa, Isaac, et al.
Publicado: (2022)

Observing the Observer (II): Deciding When to Decide
por: Daunizeau, Jean, et al.
Publicado: (2010)

A call to action—stopping antimicrobial resistance
por: Eisinger, Robert W, et al.
Publicado: (2023)

Ethical, strategic and meaningful involvement of women living with HIV starts at the beginning
por: Namiba, Angelina, et al.
Publicado: (2016)

Latin America Priorities after 40 years of the beginning of the HIV pandemic
por: Sued, Omar, et al.
Publicado: (2021)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
por: Colebunders, Robert, et al.
Publicado: (2019)

Mandatory universal masking is the key to stop COVID-19
por: Lin, Timothy PH, et al.
Publicado: (2020)

How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma
por: Raoul, Jean-Luc, et al.
Publicado: (2016)

Deciding when to exit
por: Meserve, Joy H, et al.
Publicado: (2021)

Deciding when to move
por: Sullivan, Lauren
Publicado: (2023)

Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?
por: Kura, Klodeta, et al.
Publicado: (2023)

Onchocerciasis in the Americas: from arrival to (near) elimination
por: Gustavsen, Ken, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_uh58ikp53545nsjdhluj4h4b5c